Position in GERN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,982,400
-$489,300 QoQ
Shares Held
2,330,000
0.0% QoQ
Ownership
0.363%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#35
of 258 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EDMOND DE ROTHSCHILD HOLDING S.A. holds $84,636,966 across 13 Biotechnology names. GERN ranks #7 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
687,030 | $39,311,856 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
33,660 | $9,592,090 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
113,320 | $8,985,142 | |
| 4 | BNTX |
BioNTech SE
|
92,310 | $8,589,445 | |
| 5 | MRNA |
Moderna, Inc.
|
70,747 | $4,954,411 | |
| 6 | DNLI |
Denali Therapeutics Inc.
|
165,080 | $4,245,857 | |
| 7 | GERN |
Geron Corp
This page
|
2,330,000 | $2,982,400 | |
| 8 | NRIX |
Nurix Therapeutics, Inc.
|
90,000 | $2,183,400 |
All Filings in GERN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,982,400 | 2,330,000 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $3,471,700 | 2,330,000 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,075,600 | 2,330,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,192,100 | 2,330,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,285,300 | 2,330,000 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,386,700 | 2,130,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,549,000 | 1,850,000 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $7,718,000 | 1,700,000 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||